Estadísticas de Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response
Visitas totales
| views | |
|---|---|
| Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response | 9 |
Visitas totales por mes
| views | |
|---|---|
| abril 2026 | 0 |
| mayo 2026 | 0 |
| junio 2026 | 0 |
| julio 2026 | 1 |
| agosto 2026 | 0 |
| septiembre 2026 | 2 |
| octubre 2026 | 0 |
Descargas
| views | |
|---|---|
| munoz_atogepant_2026.pdf | 98 |
Visitas por país
| views | |
|---|---|
| España | 9 |
Visitas por ciudad
| views | |
|---|---|
| Bilbao | 9 |